Literature DB >> 28905714

Cross-Foster Rederivation Compared with Antibiotic Administration in the Drinking Water to Eradicate Bordetella pseudohinzii.

Sarah E Clark1, Jeanette E Purcell2, Xuan Bi3, Jeffrey D Fortman2.   

Abstract

Bordetella pseudohinzii is a microbial agent of potential importance in mice and has confounded pulmonary research at our institution. The purpose of this study was to evaluate cross-foster rederivation and antibiotic administration in the drinking water as methods to eradicate B. pseudohinzii. To evaluate the efficacy of cross-foster rederivation, 29 litters representing 16 strains of mice were cross-fostered from cages positive for B. pseudohinzii to B. pseudohinzii-negative Crl:CD1-Elite surrogate dams. To evaluate antibiotic administration, sulfamethoxazole and trimethoprim (TMS; 0.66 and 0.13 mg/mL, respectively) and tetracycline (4.5 mg/mL) were administered in the drinking water. We assessed 3 antibiotic treatment groups with 12 B. pseudohinzii-positive cages per group (6 cages of CD1 and 6 cages of C57BL/6 mice): TMS for 4 wk, TMS for 6 wk, and tetracycline for 6 wk. Of the 29 litters that underwent cross-foster rederivation, 24 were negative for B. pseudohinzii. Five of the 12 cages treated with TMS for 4 wk and 1 of the 12 cages treated with TMS for 6 wk were negative for B. pseudohinzii at 2 wk after treatment. Three of the 12 cages treated with tetracycline were negative for B. pseudohinzii at 2 wk after treatment. Pearson χ2 analysis revealed significant association between the method of eradication (cross-foster rederivation compared with antibiotic administration) and B. pseudohinzii infection, and an odds-ratio estimate from a logistic regression demonstrated that cross-foster rederivation was more successful. Whereas antibiotic administration in the drinking water failed to eradicate B. pseudohinzii, cross-foster rederivation was successful and has been used to establish a B. pseudohinzii-negative barrier.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28905714      PMCID: PMC5250494     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  18 in total

1.  Antibiotic susceptibility of canine Bordetella bronchiseptica isolates.

Authors:  A J Speakman; S Dawson; J E Corkill; S H Binns; C A Hart; R M Gaskell
Journal:  Vet Microbiol       Date:  2000-02       Impact factor: 3.293

2.  Effects of age of pups and removal of existing litter on pup survival during cross-fostering between multiparous outbred mice.

Authors:  Debra L Hickman; Melissa P Swan
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

3.  Eliminating murine norovirus by cross-fostering.

Authors:  Laurence U Buxbaum; Pierina C DeRitis; Niansheng Chu; Pierre A Conti
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-07       Impact factor: 1.232

4.  Antibiotic administration in the drinking water of mice.

Authors:  James O Marx; Daljit Vudathala; Lisa Murphy; Shelley Rankin; F Claire Hankenson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-05       Impact factor: 1.232

5.  Successful rederivation of contaminated immunocompetent mice using neonatal transfer with iodine immersion.

Authors:  Julie Watson; Keyata N Thompson; Sanford H Feldman
Journal:  Comp Med       Date:  2005-10       Impact factor: 0.982

6.  Cross-fostering in combination with ivermectin therapy: a method to eradicate murine fur mites.

Authors:  Michael J Huerkamp; Lois A Zitzow; Sonji Webb; Jennifer K Pullium
Journal:  Contemp Top Lab Anim Sci       Date:  2005-07

7.  Optimal age at fostering for derivation of Helicobacter hepaticus-free mice.

Authors:  Kem B Singletary; Cynthia A Kloster; David G Baker
Journal:  Comp Med       Date:  2003-06       Impact factor: 0.982

8.  The use of cross-foster rederivation to eliminate murine norovirus, Helicobacter spp., and murine hepatitis virus from a mouse colony.

Authors:  James E Artwohl; Jeanette E Purcell; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-11       Impact factor: 1.232

9.  The Bordetella bronchiseptica type III secretion system is required for persistence and disease severity but not transmission in swine.

Authors:  Tracy L Nicholson; Susan L Brockmeier; Crystal L Loving; Karen B Register; Marcus E Kehrli; Sarah M Shore
Journal:  Infect Immun       Date:  2013-12-23       Impact factor: 3.441

Review 10.  Tetracycline therapy: update.

Authors:  Marilyn C Roberts
Journal:  Clin Infect Dis       Date:  2003-01-28       Impact factor: 9.079

View more
  2 in total

1.  Metaphylactic Antibiotic Treatment to Prevent the Transmission of Corynebacterium bovis to Immunocompromised Mouse Offspring.

Authors:  Emily C Pearson; Umarani Pugazhenthi; Derek L Fong; Derek E Smith; Andrew G Nicklawsky; Lauren M Habenicht; Michael K Fink; Jori K Leszczynski; Michael J Schurr; Christopher A Manuel
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-09-09       Impact factor: 1.232

2.  Airway Microbiota-Host Interactions Regulate Secretory Leukocyte Protease Inhibitor Levels and Influence Allergic Airway Inflammation.

Authors:  Natalia Jaeger; Ryan T McDonough; Anne L Rosen; Ariel Hernandez-Leyva; Naomi G Wilson; Michael A Lint; Emilie V Russler-Germain; Jiani N Chai; Leonard B Bacharier; Chyi-Song Hsieh; Andrew L Kau
Journal:  Cell Rep       Date:  2020-11-03       Impact factor: 9.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.